Healthcare / Medical Care FacilitiesTokyo
$353.00
-10.00 (-2.75%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 20%
FCF escenarios
weak_data · normalized FCF $-4.4B · quality 56.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
37/100
D
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$34.6B
P/E
12.0x
↓EV/EBITDA
7.1x
↓ROE
10.1%
↑Gross Margin
30.1%
↓Debt/Equity
1.11
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+28.7%
FCF CAGR
—
FCF margin
-8.9%
FCF / Net income
-1.20x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $49.17B · net income $3.66B · FCF $-4.40B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $49.17B | $49.17B | $42.48B | $31.98B | $23.07B |
| Net Income | $3.66B | $3.66B | $7.44B | $6.31B | $4.28B |
| EBITDA | $9.02B | $9.02B | $12.76B | $10.37B | $7.10B |
| EPS | 37.51 | 37.51 | 75.81 | 64.32 | 43.63 |
| Gross Margin | 30.1% | 30.1% | 40.2% | 41.5% | 42.0% |
| Operating Margin | 12.5% | 12.5% | 25.0% | 27.0% | 26.6% |
| Net Margin | 7.4% | 7.4% | 17.5% | 19.7% | 18.5% |
| Balance Sheet | |||||
| Debt/Equity | 1.11 | 1.11 | 0.96 | 0.87 | 0.85 |
| Current Ratio | 1.17 | 1.17 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-4.40B | $-4.40B | $-8.52B | $-3.06B | $-2.73B |
| Returns | |||||
| ROE | 10.1% | 10.1% | 22.4% | 23.8% | 20.9% |
| Valuation | |||||
| P/E | 12.02 | 12.02 | 26.18 | 42.41 | 51.09 |
| EV/EBITDA | 7.07 | 7.07 | 17.06 | 26.85 | 31.63 |
| P/B | 0.95 | 0.95 | 5.86 | 10.09 | 10.69 |
| Growth & Yield | |||||
| Revenue Growth | 15.8% | 15.8% | 32.8% | 38.6% | — |
| EPS Growth | -50.5% | -50.5% | 17.9% | 47.4% | — |
| Dividend Yield | 1.1% | 1.1% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-5.8%
EPS terminal req.
$31.32
Spread vs growth
-44.7%
5Y implied EPS CAGR
0.2%
EPS terminal req.
$37.90
Spread vs growth
-50.7%
10Y implied EPS CAGR
5.0%
EPS terminal req.
$61.04
Spread vs growth
-55.5%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-15.3%
Start / end P/E
5.6x → 9.4x
EPS bridge
75.81 → 37.51
Residual
-34.9%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.